Funding Received
$8.9 Million in 3 Rounds from 3 Investors
Most Recent Funding
$5.8 Million Series B on November 1, 2012
Headquarters:
Kirkland, WA
Description:
Resolve Therapeutics is focused on developing a novel approach to the treatment of Systemic Lupus Erythematosus (SLE).
Founders:
James Posada
Categories:
Biotechnology
Website:
http://www.resolvebio.com

Company Details

Update
Founded:
2010
Employees:
3 in CrunchBase

Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus. They are focused on the advancement their exciting, novel biologic compound, RSLV-125 from preclinical research through a phase IIa clinical trial. The company is based on the pioneering discoveries made by Dr. Keith Elkon and Dr. Jeff Ledbetter in their laboratories at the University of Washington School of Medicine.

Current Team (3)

Update

Funding Rounds (3) - $5.8M

Update

Board Members and Advisors (2)

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    5400 Carillon Point

    Kirkland, WA 98033

    USA

Images (1)

Update
  • 30a3b48673d5257a5ff89c8c997e9346